The effect of substantial weight loss with tirzepatide on heart failure with preserved ejection fraction in people with obesity (ACTRN12624000270516)

DEFINE

This trial is Coming soon
Registration number ACTRN12624000270516

Program & service

This trial is being run with the Heart & Lung service, and as part of the Cardiology program.

Trial phase

Phase 4

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principle investigator

Dr Sarah Gutman

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.